Atopic Dermatitis Clinical Trials for Adolescent

Home | Studies | Atopic Dermatitis

Living with Atopic Dermatitis?

Let Atopic Dermatitis Clinical Trials Guide the Way to Relief

Atopic Dermatitis (AD) is a chronic inflammatory skin condition that affects millions worldwide. In the U.S. alone, studies show that up to 10% of adults and 14-24% of adolescents suffer from this condition. While many treatment options exist, not all patients respond effectively to current therapies, especially those with moderate disease and intense itching.

Revival Research Institute is now enrolling participants in a clinical trial for adults and adolescents with atopic dermatitis. These studies focus on testing investigational therapies aimed at managing symptoms like itching, redness, and inflammation associated with the condition.

To qualify for the clinical trial for adults and adolescents with atopic dermatitis, participants must:

Be at least 12 years old at the time of consent
Have moderate to severe atopic hand and/or foot dermatitis
Have chronic atopic hand and/or foot dermatitis for at least 1 year prior to screening

*Additional Criteria may apply

Despite its prevalence, limited treatment options are available for patients, making clinical trials crucial in finding effective therapies. Revival Research Institute is working to evaluate innovative treatment options for atopic dermatitis in adults and adolescents.

*Who is this information for?

A Family Member

A Friend

My Patient

Please provide YOUR contact information only.

First Name

Last Name

Phone

Confirm Phone

Best time to call?

Morning

Middle of the day

Evening

State

How did you hear about us?*

Comments

User Agreement*

By checking this form, I consent to receiving SMS from Revival Research Institute, LLC.

General Communication Consent*

By checking this form, I consent to receiving phone calls from Revival Research Institute, LLC.

About the Study: A Closer Look

This atopic dermatitis clinical trial is designed specifically for a subset of patients with atopic dermatitis in adults and adolescents who experience limited body surface area involvement but significant itch burden.

Participants will receive a study drug, which is believed to play a key role in potentially limiting inflammation and itching.

Eligible participants enrolled in the study will be asked to attend regular visits, during which they may undergo physical examinations, provide blood samples, and answer questions about their medical history. A team of experienced healthcare professionals will oversee your health and progress at every step. Participation in this clinical trial is completely voluntary.

*All study procedures and study-related treatments, including the investigational drug, are provided at no cost, and no insurance is required to participate.

*To take the next step, submit the form above, and our research staff will contact you to determine if you qualify for the study. A brief discussion about your health and medical history may be required.

Get Started: What to Expect?

If you’re considering joining a clinical trial, the first step is to complete the form above. After you submit the form, someone from the research team will reach out to you by phone to ask a few questions about your health history and current medical condition. This helps determine whether you may be eligible for the study. If the potential participant is under 18, a parent or legal guardian must be involved throughout the process. They will need to provide consent for participation and may need to accompany the participant to study visits or be involved in certain decisions related to the trial.

After the screening process, once your or your child’s eligibility has been established, the research team will explain the next steps in detail. This may include reviewing the informed consent process, scheduling screening and follow-up visits, and explaining any procedures or treatments that are part of the study. Some trials may involve health-related questionnaires, sample collection, or study-related medications provided at no cost.

Your safety and privacy are always a top priority. Participation is voluntary, and you may choose to withdraw from the study at any time.

Age

12 years+

Condition

Atopic Dermatitis

Location

Troy, MI & Evans, GA

Adults & Adolescents Atopic Dermatitis: A Burning & Itching Experience

Atopic Dermatitis (AD) is a chronic, relapsing skin condition marked by intense itching, redness, dryness, and inflammation. It frequently affects areas such as the face, neck, hands, inner elbows, and knees, although it can occur anywhere on the body. In moderate to severe cases, the condition’s itch-scratch cycle can lead to skin thickening, open sores, and infections. For many, atopic dermatitis significantly affects quality of life, causing sleep disruption, emotional stress, and social withdrawal.

Skin barrier dysfunction and immune dysregulation are key contributors, with flares triggered by allergens, climate changes, and irritants. Many patients experience limited relief or treatment resistance, emphasizing the urgent need for newer therapeutic approaches. However, resistance to conventional treatments highlights the need for potential treatment options to improve patient outcomes.

Frequently Asked Questions (FAQs)

What is atopic dermatitis, and how does it affect adults and adolescents?

Atopic dermatitis in adults and adolescents is a chronic skin condition marked by dry, itchy, and inflamed skin. It can interfere with sleep, school, work, and social activities due to the discomfort and appearance of skin lesions. The severity and triggers can vary by age group but often require long-term management.

What causes atopic dermatitis in adults and adolescents?

Atopic dermatitis is caused by a combination of genetic, environmental, and immune system factors. Skin barrier dysfunction and an overactive immune response contribute to inflammation. Common triggers include allergens, irritants, stress, climate changes, and hormonal fluctuations during adolescence.

How is moderate to severe atopic dermatitis diagnosed in clinical trials?

Participants are usually diagnosed based on criteria such as Eczema Area and Severity Index (EASI), Investigator’s Global Assessment (IGA), and patient-reported itch severity using a Numerical Rating Scale (NRS). In this trial, eligibility includes 10–25% BSA involvement, an EASI score ≥16, IGA ≥3, and pruritus NRS ≥6.

Are there different treatment needs for adolescents compared to adults with AD?

Yes, adolescents may respond differently to treatments due to hormonal changes, body weight, and developing immune systems. That’s why clinical trials like this one evaluate safety and efficacy in both age groups to ensure appropriate treatment options are available for all.

Why should I consider joining a clinical trial for atopic dermatitis?

Clinical trials provide access to new investigational treatments not yet available to the public. Participants receive close medical supervision, study-related care at no cost, and contribute to the advancement of better therapies for people with atopic dermatitis.

Investigating New Therapies for Itch Relief and Skin Recovery